Insulet Corp.
$151.57
+2.64 · +1.77% today
Market open · updated 12:44:26 PM ET
- High
- $152.58 11:25 AM
- Low
- $148.93 7:40 AM
Against the S&P 500 Price change through Oct 28, 2026
PODD−47.60%
S&P 500+13.26%
PODD−54.08%
S&P 500+12.41%
PODD+11.62%
S&P 500+88.06%
PODD−51.96%
S&P 500+68.51%
Key numbers
- Previous close
- $148.93
- Open
- $150.54
- Day's range
- $150.54 – $152.60
- 52-week range
- $126.40 – $354.88
- Volume
- 269,707
- Average volume
- 1.6 million
- Market value
- $10.5 billion
- Price to earnings
- 27.8last 12 months
- Earnings per share
- $5.42last 12 months
- Beta
- 1.10moves about as much as the market
- Dividend
- None
- 50-day average
- $140.84
- 200-day average
- $180.09
Wednesday, Nov 4, 2026, before the open.
Analyst price targets and the full financials are in the terminal.
Who Insulet competes with From our value chain
Insulet in the news
No desk stories on PODD yet. When we write about it, the story leads this list.
- HeadlineInsulet (PODD) Reports Next Week: Wall Street Expects Earnings GrowthZacks Investment Research · October 28, 2026 at 11:01 AM ET
- HeadlineDaré Bioscience to Showcase Its Investigational Programmable Device, DARE-IDDS, at PODD 2026: One Device, Designed to Deliver 100+ Doses and to be Controlled WirelesslyGlobeNewsWire · October 26, 2026 at 8:32 AM ET
- HeadlineHere's Why Insulet (PODD) is a Strong Growth StockZacks Investment Research · October 16, 2026 at 10:46 AM ET
- CongressGilbert Cisneros sold $1,001 - $15,000 of PODDHouse filing · disclosed Oct 12, 2026
- CongressRo Khanna sold $1,001 - $15,000 of PODDHouse filing · disclosed Oct 9, 2026
- CongressRo Khanna bought $1,001 - $15,000 of PODDHouse filing · disclosed Oct 9, 2026
- CongressRo Khanna sold $1,001 - $15,000 of PODDHouse filing · disclosed Oct 9, 2026
- CongressGilbert Cisneros bought $1,001 - $15,000 of PODDHouse filing · disclosed Sep 11, 2026
Earnings
Next report: Wednesday, Nov 4, 2026, before the open.
Congress trades in PODD
4 purchases and 3 sales in the latest 7 filings.
| Member | Trade | Amount | Traded | Disclosed |
|---|---|---|---|---|
| Gilbert CisnerosHouse · D-California | Sale | $1,001 - $15,000 | Sep 18, 2026 | Oct 12, 2026 |
| Ro KhannaHouse · D-California | Sale | $1,001 - $15,000 | Sep 25, 2026 | Oct 9, 2026 |
| Ro KhannaHouse · D-California | Purchase | $1,001 - $15,000 | Sep 11, 2026 | Oct 9, 2026 |
| Ro KhannaHouse · D-California | Sale | $1,001 - $15,000 | Sep 4, 2026 | Oct 9, 2026 |
| Gilbert CisnerosHouse · D-California | Purchase | $1,001 - $15,000 | Aug 18, 2026 | Sep 11, 2026 |
| Ro KhannaHouse · D-California | Purchase | $1,001 - $15,000 | May 1, 2026 | Jun 11, 2026 |
| Ro KhannaHouse · D-California | Purchase | $1,000 - $15,000 | Aug 4, 2025 | Sep 12, 2025 |
Source: Periodic transaction reports filed with the House and the Senate · Members disclose ranges, not exact amounts, and may file weeks after the trade.
About Insulet
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally.
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 5,400
- Headquarters
- Acton, Massachusetts
- Website
- insulet.com
- Listed
- May 15, 2007
More medical - devices stocks
The price refreshes every 15 seconds while the market is open and carries the time it was read. Company figures are updated each evening. Built from WiseView and market data and public filings. For information only, not investment advice.